Literature DB >> 26085928

Positive Charge of "Sticky" Peptides and Proteins Impedes Release From Negatively Charged PLGA Matrices.

Stephen C Balmert1, Andrew C Zmolek2, Andrew J Glowacki3, Timothy D Knab3, Sam N Rothstein3, Joseph M Wokpetah2, Morgan V Fedorchak4, Steven R Little5.   

Abstract

The influence of electrostatic interactions and/or acylation on release of charged ("sticky") agents from biodegradable polymer matrices was systematically characterized. We hypothesized that release of peptides with positive charge would be hindered from negatively charged poly(lactic-co-glycolic acid) (PLGA) microparticles. Thus, we investigated release of peptides with different degrees of positive charge from several PLGA microparticle formulations, with different molecular weights and/or end groups (acid- or ester-terminated). Indeed, release studies revealed distinct inverse correlations between the amount of positive charge on peptides and their release rates from each PLGA microparticle formulation. Furthermore, we examined the case of peptides with net charge that changes from negative to positive within the pH range observed in degrading microparticles. These charge changing peptides displayed counterintuitive release kinetics, initially releasing faster from slower degrading (less acidic) microparticles, and releasing slower from the faster degrading (more acidic) microparticles. Importantly, trends between agent charge and release rates for model peptides also translated to larger, therapeutically relevant proteins and oligonucleotides. The results of these studies may improve future design of controlled release systems for numerous therapeutic biomolecules exhibiting positive charge, ultimately reducing time-consuming and costly trial and error iterations of such formulations.

Entities:  

Year:  2015        PMID: 26085928      PMCID: PMC4465798          DOI: 10.1039/C5TB00515A

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  31 in total

1.  Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-12-01       Impact factor: 15.470

2.  Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery.

Authors:  Jangwook Lee; Yu Jin Oh; Sang Kyung Lee; Kuen Yong Lee
Journal:  J Control Release       Date:  2010-05-26       Impact factor: 9.776

3.  Controlled growth factor delivery for tissue engineering.

Authors:  Prakriti Tayalia; David J Mooney
Journal:  Adv Mater       Date:  2009-09-04       Impact factor: 30.849

4.  Formulation and characterization of poly (beta amino ester) microparticles for genetic vaccine delivery.

Authors:  Steven R Little; David M Lynn; Sidharth V Puram; Robert Langer
Journal:  J Control Release       Date:  2005-10-20       Impact factor: 9.776

5.  Controlled release formulations of IL-2, TGF-β1 and rapamycin for the induction of regulatory T cells.

Authors:  Siddharth Jhunjhunwala; Stephen C Balmert; Giorgio Raimondi; Eefje Dons; Erin E Nichols; Angus W Thomson; Steven R Little
Journal:  J Control Release       Date:  2012-01-21       Impact factor: 9.776

6.  Peptide acylation by poly(alpha-hydroxy esters).

Authors:  Andrea Lucke; Josef Kiermaier; Achim Göpferich
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

Review 7.  The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review.

Authors:  Susanne Fredenberg; Marie Wahlgren; Mats Reslow; Anders Axelsson
Journal:  Int J Pharm       Date:  2011-05-27       Impact factor: 5.875

8.  Bioinspired controlled release of CCL22 recruits regulatory T cells in vivo.

Authors:  Siddharth Jhunjhunwala; Giorgio Raimondi; Andrew J Glowacki; Sherri J Hall; Dan Maskarinec; Stephen H Thorne; Angus W Thomson; Steven R Little
Journal:  Adv Mater       Date:  2012-07-23       Impact factor: 30.849

9.  Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro.

Authors:  M A Tracy; K L Ward; L Firouzabadian; Y Wang; N Dong; R Qian; Y Zhang
Journal:  Biomaterials       Date:  1999-06       Impact factor: 12.479

10.  Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres.

Authors:  K Fu; D W Pack; A M Klibanov; R Langer
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

View more
  10 in total

1.  * Programmed Platelet-Derived Growth Factor-BB and Bone Morphogenetic Protein-2 Delivery from a Hybrid Calcium Phosphate/Alginate Scaffold.

Authors:  Emily A Bayer; Jahnelle Jordan; Abhijit Roy; Riccardo Gottardi; Morgan V Fedorchak; Prashant N Kumta; Steven R Little
Journal:  Tissue Eng Part A       Date:  2017-06-27       Impact factor: 3.845

2.  Hollow Microparticles as a Superior Delivery System over Solid Microparticles for the Encapsulation of Peptides.

Authors:  Sharad Kharel; Archana Gautam; Andreas Dickescheid; Say Chye Joachim Loo
Journal:  Pharm Res       Date:  2018-08-02       Impact factor: 4.200

3.  Fabrication and characterization of PLGA nanoparticles encapsulating large CRISPR-Cas9 plasmid.

Authors:  Ami Jo; Veronica M Ringel-Scaia; Dylan K McDaniel; Cassidy A Thomas; Rui Zhang; Judy S Riffle; Irving C Allen; Richey M Davis
Journal:  J Nanobiotechnology       Date:  2020-01-20       Impact factor: 10.435

4.  In vivo induction of regulatory T cells promotes allergen tolerance and suppresses allergic contact dermatitis.

Authors:  Stephen C Balmert; Cara Donahue; John R Vu; Geza Erdos; Louis D Falo; Steven R Little
Journal:  J Control Release       Date:  2017-07-08       Impact factor: 11.467

Review 5.  Biologics and their delivery systems: Trends in myocardial infarction.

Authors:  Matthew A Borrelli; Heth R Turnquist; Steven R Little
Journal:  Adv Drug Deliv Rev       Date:  2021-03-26       Impact factor: 17.873

6.  TRI Microspheres prevent key signs of dry eye disease in a murine, inflammatory model.

Authors:  Michelle L Ratay; Stephen C Balmert; Abhinav P Acharya; Ashlee C Greene; Thiagarajan Meyyappan; Steven R Little
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

7.  Effect of Stabilizers on Encapsulation Efficiency and Release Behavior of Exenatide-Loaded PLGA Microsphere Prepared by the W/O/W Solvent Evaporation Method.

Authors:  Heejun Park; Dong-Hyun Ha; Eun-Sol Ha; Jeong-Soo Kim; Min-Soo Kim; Sung-Joo Hwang
Journal:  Pharmaceutics       Date:  2019-11-24       Impact factor: 6.321

8.  Cranberry extract-based formulations for preventing bacterial biofilms.

Authors:  Ashlee C Greene; Abhinav P Acharya; Sang B Lee; Riccardo Gottardi; Erin Zaleski; Steven R Little
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

9.  Nanoparticle-Mediated Angiotensin-(1-9) Drug Delivery for the Treatment of Cardiac Hypertrophy.

Authors:  Sabrina Sepúlveda-Rivas; Matías S Leal; Zully Pedrozo; Marcelo J Kogan; María Paz Ocaranza; Javier O Morales
Journal:  Pharmaceutics       Date:  2021-06-01       Impact factor: 6.321

10.  Ultrahigh verapamil-loaded controlled release polymeric beads using superamphiphobic substrate: D-optimal statistical design, in vitro and in vivo performance.

Authors:  Carol Yousry; Maha M Amin; Ahmed H Elshafeey; Omaima N El Gazayerly
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.